Literature DB >> 21525965

Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient.

Érika A Furusawa1, Ulysses D Filho, Décio Mion Junior, Vera H Koch.   

Abstract

OBJECTIVE: To evaluate the effect of the environment and the observer on the measurement of blood pressure (BP) as well as to compare home BP (HBP) and ambulatory BP (ABP) measurements in the diagnosis of white coat hypertension (WCH) and masked hypertension (MH) in children and adolescents with hypertension (HT).
METHODS: BP of 40 patients with HT (75% of which had secondary HT and were on antihypertensive medication), mean age 12.1 years was evaluated through casual measurements at the clinic and at the HT unit, HBP for 14 days with the OMRON HEM 705 CP monitor (Omron, Tokyo, Japan) and ABP performed with SPACELABS 90207 (Spacelabs, Redmond, WA), for 24 h.
RESULTS: HT was diagnosed at the doctor's office by ABP and HBP in 30/40, 27/40, and 31/40 patients, respectively. Based on office BP and ABP, 60% of patients were normotensive, 17.5% HT, 7.5% had WCH, and 15% had MH, whereas based on office BP and HBP 65, 12.5, 10, and 12.5% of patients were classified according to these diagnoses, respectively. There was considerable diagnostic agreement of HT by ABP and HBP (McNemar test, P < 0.01) (κ = 0.56).
CONCLUSION: In hypertensive children and adolescents, HBP and ABP present comparable results. HBP appears to be a useful diagnostic test for the detection of MH and WCH in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525965     DOI: 10.1038/ajh.2011.72

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Home Blood Pressure Monitoring in Children and Adolescents: Systematic Review of Evidence on Clinical Utility.

Authors:  George Stergiou; Emelina Stambolliu; Ioanna Bountzona; Angeliki Ntineri; Anastasios Kollias; Andriani Vazeou; Alexandra Soldatou
Journal:  Curr Hypertens Rep       Date:  2019-06-25       Impact factor: 5.369

2.  The prevalence of masked hypertension and masked uncontrolled hypertension in relation to overweight and obesity in a nationwide registry in China.

Authors:  Jia-Hui Xia; Dong-Yan Zhang; Yuan-Yuan Kang; Qian-Hui Guo; Yi-Bang Cheng; Jian-Feng Huang; Qi-Fang Huang; Wei Zhang; Li-Juan Zhang; Yu Dou; Yan-Lun Su; Hua-Ling Liu; Mei-Sheng Zheng; Xin-Juan Xu; Jian-Jun Mu; Yan Li; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2022-09-14       Impact factor: 5.528

Review 3.  Role of ambulatory blood pressure monitoring in hypertension and diabetes.

Authors:  Colleen Flynn; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

4.  Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association.

Authors:  Joseph T Flynn; Stephen R Daniels; Laura L Hayman; David M Maahs; Brian W McCrindle; Mark Mitsnefes; Justin P Zachariah; Elaine M Urbina
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

Review 5.  Pediatric ambulatory blood pressure monitoring: indications and interpretations.

Authors:  Joseph T Flynn; Elaine M Urbina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-07       Impact factor: 3.738

6.  Prospective analysis of utility and feasibility of ambulatory blood pressure monitoring service in a pediatric nephrology set up.

Authors:  R Sinha
Journal:  Indian J Nephrol       Date:  2013-11

Review 7.  White coat hypertension in pediatrics.

Authors:  Alexander Jurko; Milan Minarik; Tomas Jurko; Ingrid Tonhajzerova
Journal:  Ital J Pediatr       Date:  2016-01-15       Impact factor: 2.638

8.  High Blood Pressure among Students in Public and Private Schools in Maceió, Brazil.

Authors:  Haroldo S Ferreira; Glícia Maris A Lúcio; Monica L Assunção; Bárbara Coelho V Silva; Juliana S Oliveira; Telma Maria M T Florêncio; Amandio Aristides R Geraldes; Bernardo L Horta
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.